Medtronic came out with two pieces of news yesterday around its connected diabetes efforts: an FDA clearance for a hybrid closed loop insulin delivery system and the first test cohort of its Sugar.IQ app, created in collaboration with IBM Watson.
The FDA approval of Medtronic’s MiniMed 670G hybrid closed looped system was announced by the FDA itself, as it’s the first automated insulin delivery...
Medtronic has received a CE Mark for its Guardian Connect mobile continuous glucose monitor (CGM) and app. The company will begin selling the system in select countries in Europe, Asia, and Latin America in Q2 2017 and expects to receive FDA clearance to launch the device in the US around that same time.
The Dublin, Ireland-based company already has an FDA and CE cleared connected CGM called...
Medtronic has launched its MiniMed Connect system, which allows people with diabetes who use both a Medtronic continuous glucose monitor (CGM) and a Medtronic insulin pump to see data from both device on their smartphone, and send it to their caregiver.
"It’s part of our plan to become a holistic diabetes management company," Annette Brüls, President of the Diabetes Service and Solutions business...
Medtronic has received FDA 510(k) clearance for its MiniMed Connect device, which allows users of Medtronic's continuous glucose monitor (CGM) and insulin pump to view data from those devices on their smartphone. At the same time, Medtronic announced a partnership with Samsung to optimize the viewing of this CGM and pump data.
The MiniMed Connect device is a keychain-sized device that users of...
